ASCENDIA PHARMACEUTICALS, INC. — SEC Form D Filing

ASCENDIA PHARMACEUTICALS, INC. filed an SEC Form D on July 24, 2026, reporting $4.08M raised in Other Health Care.

Form D filing details

Filing
SEC Form D
Filing date
July 24, 2026
Amount reported
$4.08M
Round stage
Seed
Industry
Other Health Care
Website
https://ascendiapharma.com

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Pharmaceutical companies struggle to efficiently develop and scale new drug formulations due to complex scientific challenges and regulatory hurdles.

Solution

ASCENDIA PHARMACEUTICALS, INC. provides specialized contract development and manufacturing services for complex pharmaceutical formulations, helping clients bring new drugs to market faster and more reliably.

Why now

The specific timing catalyst for ASCENDIA PHARMACEUTICALS is unclear from available information.

Source: SEC EDGAR Form D filing